-+ 0.00%
-+ 0.00%
-+ 0.00%

What ASMPT Doubters Got Wrong

Simply Wall St·10/15/2026 11:35:36
语音播报

If you only glanced at ASMPT headlines, recent AI orders and awards might make the strong share price look obvious in hindsight. For ASMPT shareholders, the return from the start of the year was 69.7%, including dividends. If you had been weighing an investment decision on 1 January 2026, you would have faced sharply different analyst stories about advanced packaging and geopolitical risk. So what did that split view really say about the business you were betting on?

Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.

ASMPT is not the only name tied to this theme. Zero in on 92 AI infrastructure stocks and compare how each one is priced.

The Two ASMPT Stories Investors Had To Weigh

The shares cost HK$77.45 at the start of the period, and anyone looking at ASMPT then had to choose between two sharply different stories about its future.

The bullish narrative argued for a fair value of HK$100. Supporters leaned on ASMPT's leadership in Thermo Compression Bonding and active oxide removal for HBM4, assuming this position could help it capture incremental market share in advanced packaging.

The bearish side anchored on a fair value of HK$67. That view focused on the risk that export controls and market access limits could reduce ASMPT's exposure to key regions such as China and leave it with a smaller long term revenue base.

SEHK:522 Trailing 12-Month Earnings & Revenue History as at Oct 2026
SEHK:522 Trailing 12-Month Earnings & Revenue History as at Oct 2026

What The Results Changed For The ASMPT Story

Record AI driven bookings and revenue in early 2026, including the Q2 2026 move from HK$3,342.2m to HK$4,935.8m and higher net income, leaned toward the bullish ASMPT case that focused on advanced packaging strength. A repeat Thermo Compression Bonding tool order from a major customer pointed the same way. Rising net margin to 8.5% meant profitability assumptions were tested rather than settled.

The key lesson is simple. When a thesis hangs on technology leadership and richer margins, you check two things in every result: segment bookings tied to that product, and the reported net margin trend.

What Today's ASMPT Price Already Assumes

ASMPT now trades at HK$136, up 69.7% from the start of the year. This selected Narrative therefore places its Fair Value below where the market currently prices the stock.

The Narrative leans on strong AI related bookings but highlights long order cycles and backlog quality as pressure points. A buyer today effectively banks on ASMPT turning that AI backlog into sustained high margin revenue while absorbing higher R&D and IT costs.

"Although ASMPT points to strong AI related bookings across TCB, photonics and SMT, longer lead times for key materials and 6 to 9 month manufacturing and order conversion cycles mean any slowdown in customer capex could leave a large portion of the current backlog at risk of delay or repricing, which would pressure future revenue recognition and working capital."

That disagreement has a full argument behind it. → Uncover the lower Fair Value this Narrative argues for

Where ASMPT’s Demand Connects Next

Once you understand ASMPT’s advanced packaging angle, another question appears. Where does all that processed data actually travel and run?

Every AI heavy workload needs dependable connections, fast storage access and secure traffic control.

One large infrastructure supplier concentrates on these essential plumbing jobs across digital networks.

This business builds networking chips and software that move, secure and manage immense data flows inside data centers.

Picture it as a utility layer keeping infrastructure responsive when compute demand suddenly shifts direction.

That argument has a Narrative and a number behind it. → See the company one Narrative values 88% above its price

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.